← Back to All Filings

Twist Bioscience CEO Files Intent to Sell ~$987k in Stock (TWST)

Low SignificanceOctober 30, 2025 at 4:02:15 PM EDT

Twist Bioscience Corp

$TWST144CIK: 0001581280

Subscribe to track TWST

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Twist Bioscience CEO Files Intent to Sell ~$987k in Stock (TWST)

Company: Twist Bioscience Corp (TWST) Form: 144 | Filed: 2025-10-30 Significance: Low

Insider: Leproust Emily M. Title: Officer | Relationship: Officer, Director

Transaction (Proposed): • Type: Sale • Shares: 31,379 • Value: $986,690.69 • Price/Share (approx): $31.44

Key Insight: This is a proposed 'sell-to-cover' transaction to satisfy tax obligations on vested stock awards. Such sales are often pre-planned and not indicative of a change in the insider's outlook.

Market Context: The sale represents ~0.05% of shares outstanding and ~0.05% of the company's $2.06B market cap, making it a low-impact event.

Comprehensive Analysis

SEC Filing Analysis: Twist Bioscience Corp (TWST)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: An Officer and Director, Emily M. Leproust, has filed a notice of proposed sale for 31,379 shares valued at approximately $987k. The filing indicates this is a 'sell-to-cover' transaction to meet tax obligations from vested equity awards.
  • Market Impact: The transaction is of low materiality, representing a negligible percentage of the company's market capitalization and shares outstanding, suggesting a minimal market impact.

Company Information

FieldValue
CompanyTwist Bioscience Corp
Ticker SymbolTWST
CIK0001581280
IndustryBIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)

Insider Information

FieldValue
NameLeproust Emily M.
CIK0001753655
Title/PositionOfficer
RelationshipOfficer, Director

Transaction Details

FieldValue
Form Type144
Transaction Date2025-10-30 (Approximate Sale Date)
Transaction Codenull
Security TypeCommon Stock
Shares Involved31,379
Price Per Share$31.44 (approximate)
Total Value$986,690.69
Shares Owned AfterNot specified
Ownership TypeNot specified

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$986,690.69
% of Market Cap0.048%
Shares Transacted31,379
% of Shares Outstanding0.052%
Post-Transaction OwnershipNot specified
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $2.06 billion, this transaction of under $1 million is minor and unlikely to influence market perception.
  • Ownership Concentration: Without post-transaction ownership data, it's impossible to assess the change in the insider's holdings. However, the sale itself is a small fraction of the total shares outstanding.
  • Dilution Impact: This is a sale of existing shares, not an issuance, so there is no dilutive impact on shareholders.
  • Transaction Significance: The sale represents just 0.048% of the market cap and 0.052% of shares outstanding. Both metrics are well below the thresholds for moderate or high significance, confirming this as a routine, low-impact transaction.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The sale is explicitly linked to covering tax obligations from vested stock, which is a common and often automated practice for executives. It is not typically interpreted as a discretionary sale based on the company's future prospects. The small size of the sale relative to the company's market cap further supports a neutral outlook.

Volume & Sentiment

  • Expected Volume Impact: Minimal. The transaction size is not large enough to cause a significant spike in trading volume.
  • Sentiment Indicator: Neutral. The context of a 'sell-to-cover' action negates any potential bearish sentiment that might arise from an insider sale.

Investment Insights

Positive Market Indicators

  • The transaction is not a discretionary sale, which can be viewed as a neutral-to-positive signal (i.e., the insider is not actively choosing to reduce their exposure).

Risk Factors

  • The filing notes several other sales by the same insider in the preceding three months. While this proposed sale is for tax purposes, a pattern of consistent selling could warrant monitoring.

Key Takeaways

  1. Low Significance Sale: An Officer and Director intends to sell shares worth ~$987k, a transaction of low materiality for a $2.06B company.
  2. Tax-Motivated Transaction: The filing explicitly states the sale is to cover tax obligations from vested equity, making it a non-discretionary event that does not signal a change in insider confidence.
  3. Minimal Market Impact: Due to its small size and non-discretionary nature, the proposed sale is not expected to have a meaningful impact on the stock price or investor sentiment.

Additional Context

Transaction Notes

  • Special Circumstances: The filing remarks state: "Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution." This is a classic 'sell-to-cover' transaction.
  • Market Environment: The analysis is based on the data provided and does not account for broader market or sector-specific trends at the time of the proposed sale.
Topics:#SECFiling#InsiderTrading#TWST#TwistBioscience#Form144#InsiderSell#Biotech#StockMarket#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.